Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000710795 | SCV000841099 | uncertain significance | not provided | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000710795 | SCV001091527 | benign | not provided | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000989165 | SCV001139385 | benign | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV002247414 | SCV002097991 | uncertain significance | Brain small vessel disease 1 with or without ocular anomalies | 2020-06-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710795 | SCV004034902 | uncertain significance | not provided | 2024-03-12 | criteria provided, single submitter | clinical testing | Identified in patients with small vessel disease and intracranial hemorrhage in published literature (PMID: 22522439, 31719132, 35711275, Aref2024[article]); Functional studies suggest that p.(P352L) results in reduced ratio of extracelluar to intracellular COL4A1 compared to controls (PMID: 22522439); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29114093, 31857254, 34382650, Kiss2019, 22914737, 30518145, 22522439, 34426522, Aref2024[article], 31719132, 35711275, 30476936) |
OMIM | RCV000033090 | SCV000056870 | risk factor | Hemorrhage, intracerebral, susceptibility to | 2012-04-01 | no assertion criteria provided | literature only |